Literature DB >> 33006052

The Pivotal Role of Mitsugumin 53 in Cardiovascular Diseases.

Wenhua Jiang1, Manling Liu2, Chunhu Gu3, Heng Ma4.   

Abstract

The MG53 (also known as TRIM72) is a conserved, muscle-specific tripartite motif family protein that is abundantly expressed in cardiac or skeletal muscle and present in circulation. Recently, the MG53 had been hypothesized to serve a dual role in the heart: involving in repairing cell membranes that protect myocardial function while acting as an E3 ligase to trigger insulin resistance and cardiovascular complications. This review discusses the roles of MG53 in cardiac physiological function with emphasis on MG53 protective function in the heart and its negative impact on the myocardium due to the continuous elevation of MG53. Besides, this work reviewed the significance of MG53 as a potential therapeutic in human cardiovascular diseases. Despite the expression of MG53 being rare in the human, thus exogenous MG53 can potentially be a new treatment for human cardiovascular diseases. Notably, the specific mechanism of MG53 in cardiovascular diseases remains elusive.

Entities:  

Keywords:  Cardiovascular diseases; Insulin resistance; Ischemic cardiomyopathy; MG53

Year:  2020        PMID: 33006052     DOI: 10.1007/s12012-020-09609-y

Source DB:  PubMed          Journal:  Cardiovasc Toxicol        ISSN: 1530-7905            Impact factor:   3.231


  67 in total

1.  Cardioprotection of ischemia/reperfusion injury by cholesterol-dependent MG53-mediated membrane repair.

Authors:  Xianhua Wang; Wenjun Xie; Yi Zhang; Peihui Lin; Liang Han; Peidong Han; Yanru Wang; Zheng Chen; Guangju Ji; Ming Zheng; Noah Weisleder; Rui-Ping Xiao; Hiroshi Takeshima; Jianjie Ma; Heping Cheng
Journal:  Circ Res       Date:  2010-05-13       Impact factor: 17.367

2.  TRIM72, a novel negative feedback regulator of myogenesis, is transcriptionally activated by the synergism of MyoD (or myogenin) and MEF2.

Authors:  Soon-Young Jung; Young-Gyu Ko
Journal:  Biochem Biophys Res Commun       Date:  2010-04-23       Impact factor: 3.575

3.  Lipid-binding properties of TRIM72.

Authors:  Sunghyen Kim; Jeonghwa Seo; Young-Gyu Ko; Young-Duk Huh; Heonyong Park
Journal:  BMB Rep       Date:  2012-01       Impact factor: 4.778

4.  MG53, A Novel Regulator of KChIP2 and Ito,f, Plays a Critical Role in Electrophysiological Remodeling in Cardiac Hypertrophy.

Authors:  Wenjuan Liu; Gang Wang; Cuicui Zhang; Wenwen Ding; Wanwen Cheng; Yizhi Luo; Chaoliang Wei; Jie Liu
Journal:  Circulation       Date:  2019-04-30       Impact factor: 29.690

5.  Redox-dependent oligomerization through a leucine zipper motif is essential for MG53-mediated cell membrane repair.

Authors:  Moonsun Hwang; Jae-Kyun Ko; Noah Weisleder; Hiroshi Takeshima; Jianjie Ma
Journal:  Am J Physiol Cell Physiol       Date:  2011-04-27       Impact factor: 4.249

6.  TRIM72 negatively regulates myogenesis via targeting insulin receptor substrate-1.

Authors:  C S Lee; J-S Yi; S-Y Jung; B-W Kim; N-R Lee; H-J Choo; S-Y Jang; J Han; S-G Chi; M Park; J-H Lee; Y-G Ko
Journal:  Cell Death Differ       Date:  2010-02-05       Impact factor: 15.828

7.  MG53 nucleates assembly of cell membrane repair machinery.

Authors:  Chuanxi Cai; Haruko Masumiya; Noah Weisleder; Noriyuki Matsuda; Miyuki Nishi; Moonsun Hwang; Jae-Kyun Ko; Peihui Lin; Angela Thornton; Xiaoli Zhao; Zui Pan; Shinji Komazaki; Marco Brotto; Hiroshi Takeshima; Jianjie Ma
Journal:  Nat Cell Biol       Date:  2008-11-30       Impact factor: 28.824

Review 8.  Dual function of MG53 in membrane repair and insulin signaling.

Authors:  Tao Tan; Young-Gyu Ko; Jianjie Ma
Journal:  BMB Rep       Date:  2016-08       Impact factor: 4.778

Review 9.  TRIM family proteins: retroviral restriction and antiviral defence.

Authors:  Sébastien Nisole; Jonathan P Stoye; Ali Saïb
Journal:  Nat Rev Microbiol       Date:  2005-10       Impact factor: 60.633

10.  Treatment of acute lung injury by targeting MG53-mediated cell membrane repair.

Authors:  Yanlin Jia; Ken Chen; Peihui Lin; Gissela Lieber; Miyuki Nishi; Rosalie Yan; Zhen Wang; Yonggang Yao; Yu Li; Bryan A Whitson; Pu Duann; Haichang Li; Xinyu Zhou; Hua Zhu; Hiroshi Takeshima; John C Hunter; Robbie L McLeod; Noah Weisleder; Chunyu Zeng; Jianjie Ma
Journal:  Nat Commun       Date:  2014-07-18       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.